PRODIET acquired by NUTRISENS
Context
Nutrisens Group has acquired a majority stake in Prodiet Medical Nutrition, a Brazilian leader in clinical nutrition. The founders of Prodiet, Armando Tortelli and Ana Paula Celes, retain a minority stake and will continue to support the company's growth, while Gabriel Tortelli remains as CEO. This acquisition marks a major step in Nutrisens' international expansion strategy, providing a strong platform to address the Latin American market. The deal is expected to generate significant commercial synergies through cross-selling portfolios and optimizing innovation and sourcing capabilities.
PRODIET, which reported an EBITDA margin of [members only] in 2024, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded in 2005, Prodiet Medical Nutrition is a fast-growing specialist in clinical nutrition. The company develops and manufactures a wide range of oral and enteral nutrition products (liquids and powders) for patients with specific needs, such as neurological conditions, post-surgery recovery, and oncology. Prodiet operates two production facilities in Curitiba and employs approximately 200 people. It distributes its products through hospitals, pharmacies, and e-commerce across Brazil and exports to international markets.
Ent. Value
€25–50M
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Similar deals in Life Sciences
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 04/2025 | Knop Investments | AVANCE CARE GROUP | NETHERLANDS | Medical Devices |
| 04/2025 | CINVEN | NUTRISENS | FRANCE | Nutrition & Dietary Supplements |
| 03/2025 | SIPAREX | LABORATOIRE POLIDIS | FRANCE | Medical Consumables |
| 03/2025 | ZYDUS | AMPLITUDE SURGICAL | FRANCE | Implants & Prosthetics |
| 03/2025 | LBO FRANCE | HEMODIA | FRANCE | Medical Devices |
| 02/2025 | NOVONESIS | FEED ENZYME ALLIANCE | DENMARK | Animal Health |
| 02/2025 | EURAZEO / TURENNE CAPITAL / KURMA PARTNERS | GERMITEC | FRANCE | Medical Devices |
| 01/2025 | Animalcare Group | Randlab | AUSTRALIA | Animal Health |
| 01/2025 | QUADRIVIO GROUP | MIR - MEDICAL INTERNATIONAL RESEARCH | ITALY | Diagnostic Equipment |
| 12/2024 | UI INVESTISSEMENT | DIDACTIC | FRANCE | Medical Consumables |
REFERENCES
Revenue range: €25–50M
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of PRODIET by NUTRISENS are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.